Ready to accelerate your clinical trial? Visit bioaccess® →
Global Trial Accelerators™
Global Trial Accelerators™
Accelerate Your Path from First-in-Human to Exit Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is the only podcast for healthcare startup founders and innovators navigating first-in-human (FIH) clinical trials. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials — serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who've compressed timelines, reduced costs, and generated the clinical evidence investors demand — by leveraging Latin America's clinical research infrastructure. What You'll Learn: - Regulatory pathways across 10+ Latin American countries (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay) - Why ethics approval in 4-8 weeks (vs. 6-12 months in US/EU) changes the game for startups - Strategies to generate FIH data that unlocks your next funding round or acquisition - The Innovation Runway: from prototype to clinical milestones before capital runs out - Case studies from 58+ companies — seed-stage startups to Fortune 500 MedTech - Decentralized trials, AI-driven recruitment, and post-trial commercialization "bioaccess® compressed our timeline by 9 months vs. our US plan. This podcast is why we partnered with them." – Digital Health Startup CEO New episodes weekly. Subscribe to unlock your shortcut from first-in-human to exit. Brought to you by bioaccess® — an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
Choose your favorite podcast player
Aug. 27, 2021

Luiz Levy, Director & Quality and Regulatory Affairs at Emergo

Luiz Levy has over ten years of medical device industry experience, primarily focused on high-risk devices, including implantable devices, electrical medical equipment, and disposables subject to INMETRO Certification. Luiz’s background includes: implementing and auditing quality systems to B-GMP Regulation RDC 16/2013, ISO 13485:2016, Directive 93/42/EEC, Regulation (EU) 2017/745, FDA 21 CFR 807, FDA QSR 21 CFR 820, MDSAP-Medical device Single audit program; performing multiple local and foreign (US, Europe, Japan) audits to prepare companies for ANVISA inspections; assisting companies during ANVISA inspections; compiling medical device and IVD applications; clinical data review; compiling clinical evaluation reports and compiling and peer-reviewing market access reports.

As Director, Quality and Regulatory Affairs, Luiz has peer-reviewed more than 300 regulatory filings and reports, conducted multiple onsite audits on local and foreign manufactures, performed internal audits, and performed or reviewed more than 350 classifications/technical files of healthcare products, attended strategic meetings with ANVISA to help Agency on the final draft of new regulations (RDCs). Luiz is the designated Health Manager for Emergo’s Brazil Registration Holder services, and he additionally managers Emergo Brazil’s RDC 16/2013 quality system. Prior to Emergo, Luiz held RA/QA positions at CPL Medicals, Goen3, and Medics.

Related to this Episode

Navigating INMETRO Certification for Medical Devices: A Comprehensive Guide

Navigating the regulatory landscape for medical devices can be a complex undertaking, especially when expanding into new markets like Brazil. One crucial aspect of this process is obtaining INMETRO certification. This blog post aims to demystify INM…